Figure 2From: Impact of innate immunity in a subset of children with autism spectrum disorders: a case control studyLower IL-10 production with a TLR2/6 agonist in the ASD-test group without LPS pre-treatment. IL-10 production with a TLR2/6 agonist was lower in the ASD-test group than in the ASD case controls.Back to article page